SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-007811
Filing Date
2017-10-31
Accepted
2017-10-31 16:03:39
Documents
45
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20170930x10q.htm 10-Q 1027547
2 EX-1.1 mrns-20170930ex110f5e834.htm EX-1.1 291134
3 EX-31.1 mrns-20170930ex31151e9d9.htm EX-31.1 15235
4 EX-31.2 mrns-20170930ex312462b87.htm EX-31.2 15378
5 EX-32.1 mrns-20170930ex321986744.htm EX-32.1 9480
6 GRAPHIC mrns20170930x10q001.jpg GRAPHIC 23678
  Complete submission text file 0001558370-17-007811.txt   3343052

Data Files

Seq Description Document Type Size
7 EX-101.INS mrns-20170930.xml EX-101.INS 493366
8 EX-101.SCH mrns-20170930.xsd EX-101.SCH 19680
9 EX-101.CAL mrns-20170930_cal.xml EX-101.CAL 29482
10 EX-101.DEF mrns-20170930_def.xml EX-101.DEF 65331
11 EX-101.LAB mrns-20170930_lab.xml EX-101.LAB 220081
12 EX-101.PRE mrns-20170930_pre.xml EX-101.PRE 150251
Mailing Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087
Business Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 171165733
SIC: 2834 Pharmaceutical Preparations